Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-02-21

Clinical Trial Update: Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis [NA]

View source ↗

Summary

A clinical trial evaluating efficacy and safety for knee osteoarthritis sponsored by Pierre Fabre Medicament has been withdrawn (NCT01469507).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational product (unspecified)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Knee Osteoarthritis | NA | Status: WITHDRAWN